Hold Parameters on Likely Cardiovascular Depressant Medications
This trial is active, not recruiting.
|Conditions||asystole, bradycardia, hypotension|
|Sponsor||Hackensack University Medical Center|
|Start date||August 2006|
|End date||August 2006|
|Trial identifier||NCT00527709, 06.01.025|
This pilot study is being pursued to observe whether certain medications are given to patients within a timeframe where their being given could play a part in a critical event in the management of the patient.
There are general rules about when it would be appropriate for these types of medications not to be given. However, it is not current standard practice for the criteria to be put in place without the expressed wishes of the ordering physician or their agent.
Can the administration of cardio-depressant medications be documented as a significant risk factor for hypotensive or bradycardic events?
Male or female participants of any age.
Inclusion Criteria: - Serial evaluation of the first 50 documented events of Code Blue or call to Rapid Response Team involving hypotension, bradycardia or asystole in the adult inpatient population events beginning January 1, 2006.
|Official title||Hold Parameters on Likely Cardiovascular Depressant Medications (HOLD)|
|Principal investigator||Amit Tailor, MD, MBA|
Call for more information